These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM; Yu SC; Lin CC J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949 [TBL] [Abstract][Full Text] [Related]
5. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials. Tammenmaa IA; Sailas E; McGrath JJ; Soares-Weiser K; Wahlbeck K Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1099-107. PubMed ID: 15610922 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of donepezil in the treatment of elderly patients with tardive movement disorders. Bergman J; Dwolatzky T; Brettholz I; Lerner V J Clin Psychiatry; 2005 Jan; 66(1):107-10. PubMed ID: 15669896 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives. Kulkarni SK; Naidu PS Drugs Today (Barc); 2003 Jan; 39(1):19-49. PubMed ID: 12669107 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia. Rapaport A; Sadeh M; Stein D; Levine J; Sirota P; Mosheva T; Stir S; Elitzur A; Reznik I; Geva D; Rabey JM Mov Disord; 2000 Mar; 15(2):352-5. PubMed ID: 10752596 [No Abstract] [Full Text] [Related]
9. Clinical forms of severe tardive dyskinesia. Gardos G; Cole JO; Salomon M; Schniebolk S Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062 [TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial. Lee JG; Shin BS; Lee YC; Park SW; Kim YH Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029 [TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. Kane JM J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107 [TBL] [Abstract][Full Text] [Related]
12. A clinical trial of nifedipine in schizophrenia and tardive dyskinesia. Suddath RL; Straw GM; Freed WJ; Bigelow LB; Kirch DG; Wyatt RJ Pharmacol Biochem Behav; 1991 Jul; 39(3):743-5. PubMed ID: 1686106 [TBL] [Abstract][Full Text] [Related]
13. The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population. Brar JS; Parepally H; Chalasani L; Gopalani A; Appel N; Chengappa KN Ann Clin Psychiatry; 2008; 20(3):139-44. PubMed ID: 18633740 [TBL] [Abstract][Full Text] [Related]
14. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study. Shriqui CL; Bradwejn J; Annable L; Jones BD Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951 [TBL] [Abstract][Full Text] [Related]
15. Is tardive dyskinesia a unique disorder? Marsden CD Psychopharmacology Suppl; 1985; 2():64-71. PubMed ID: 2860661 [TBL] [Abstract][Full Text] [Related]
16. The treatment of tardive dyskinesia and tardive dystonia. Simpson GM J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330 [TBL] [Abstract][Full Text] [Related]
17. [Torticollis spasmodicus as a manifestation of tardive dystonia]. Silberbauer C; Rittmannsberger H Fortschr Neurol Psychiatr; 1995 Oct; 63(10):388-92. PubMed ID: 8529987 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Response to Clozapine and Its Clinical Correlates in the Treatment of Tardive Movement Syndromes: A Naturalistic Observational Study in Patients With Psychotic Disorders. Lee D; Baek JH; Bae M; Choi Y; Hong KS J Clin Psychopharmacol; 2019; 39(6):591-596. PubMed ID: 31688397 [TBL] [Abstract][Full Text] [Related]
19. Cognitive functions in tardive dyskinesia. Wolf ME; Ryan JJ; Mosnaim AD Psychol Med; 1983 Aug; 13(3):671-4. PubMed ID: 6137851 [TBL] [Abstract][Full Text] [Related]